DANA SULLIVAN: Open Payments
NPI 1245998053 · EVESHAM, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 73 payments from 16 companies in 2025. Trend: 2023 $1,126 · 2024 $976 · 2025 $1,263
Food & beverage: $1,263
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $235 |
| ABBVIE INC. | 13 | $204 |
| Neurocrine BioSciences, Inc. | 7 | $137 |
| Axsome Therapeutics, Inc. | 6 | $112 |
| Vanda Pharmaceuticals Inc. | 6 | $104 |
| Lundbeck LLC | 6 | $101 |
| Collegium Pharmaceutical, Inc. | 4 | $72 |
| Alkermes, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
Products named: REXULTI, VRAYLAR, INGREZZA, Auvelity, FANAPT, Jornay PM, ARISTADA, TRINTELLIX.
Industry payments across NJ — which companies pay providers there.
